[Treatment of heart failure and shock].
D002316:Cardiotonic Agents / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006333:Heart Failure / Q000188:drug therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D009203:Myocardial Infarction / Q000150:complications*; D012770:Shock, Cardiogenic / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000627:therapeutic use
D002316:Cardiotonic Agents; D014665:Vasodilator Agents
Behandlung von Herzinsuffizienz und Schock.